3P Exploratory efficacy analysis by smoking status in PD-L1 high patients in the phase III, non-small cell lung cancer (NSCLC) IMpower110 study
Saved in:
Published in | Immuno-oncology technology Vol. 20; p. 100474 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.12.2023
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 2590-0188 2590-0188 |
---|---|
DOI: | 10.1016/j.iotech.2023.100474 |